IPNEX

Licensable university IP

Combination therapy for cancer

Combination therapy for cancer is marketed for licensing by Stanford University (OTL). It is documented in US patent US 12,605,371. The current assignee of record is United States Governmment Represented By Department Of Veterans Affairs AS. Google Patents reports its legal status as “Active” (an automated indicator, not a legal determination). Its expected expiration is 2043-02-16. Note: the patent's assignee of record is United States Governmment Represented By Department Of Veterans Affairs AS, not Stanford University (OTL); confirm that Stanford University (OTL) can license it before relying on this listing.

The patent's current assignee of record is United States Governmment Represented By Department Of Veterans Affairs AS, which differs from the marketing institution (Stanford University (OTL)). Confirm licensing rights with the assignee of record before relying on this listing.

Patent picture

FieldValueReliabilitySource
US patentUS 12,605,37195%HighGoogle Patents
Patent titleCombination therapy for cancer90%HighGoogle Patents
Current assigneeUnited States Governmment Represented By Department Of Veterans Affairs AS80%GoodGoogle Patents
Original assigneeUnited States Governmment Represented By Department Of Veterans Affairs AS85%GoodGoogle Patents
Legal statusActive70%ModerateGoogle Patents
Filing date2021-07-2690%HighGoogle Patents
Priority date2020-07-3190%HighGoogle Patents
Publication date2026-04-2190%HighGoogle Patents
Expected expiration2043-02-1675%ModerateGoogle Patents
Reliability of each field, at a glance:
  • High 90% and up
  • Good 80 to 89%
  • Moderate 70 to 79%
Hover a bar for the exact figure; the Source column links the citation.

Legal status is Google Patents' automated indicator, not a legal determination.

Joined to US 12,605,371 by its printed patent number (a deterministic match), then enriched from public Google Patents data. Fields are shown only where resolved against a public source; unresolved fields are omitted, never guessed.

Original listing

This technology is marketed for licensing by Stanford University (OTL). View the original listing.